Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines

In head and neck cancers, the effectiveness of cisplatin (CisPt) treatment is limited by its toxicity, especially when higher doses are necessary, and the possible occurrence of cisplatin resistance. This study evaluated the effects of resveratrol (RSV) on the expression of different genes involved...

Full description

Bibliographic Details
Main Authors: Marinela Bostan, Mirela Mihaila, Georgiana Gabriela Petrica-Matei, Nicoleta Radu, Razvan Hainarosie, Cristian Dragos Stefanescu, Viviana Roman, Carmen Cristina Diaconu
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/12/6322
_version_ 1797530300472885248
author Marinela Bostan
Mirela Mihaila
Georgiana Gabriela Petrica-Matei
Nicoleta Radu
Razvan Hainarosie
Cristian Dragos Stefanescu
Viviana Roman
Carmen Cristina Diaconu
author_facet Marinela Bostan
Mirela Mihaila
Georgiana Gabriela Petrica-Matei
Nicoleta Radu
Razvan Hainarosie
Cristian Dragos Stefanescu
Viviana Roman
Carmen Cristina Diaconu
author_sort Marinela Bostan
collection DOAJ
description In head and neck cancers, the effectiveness of cisplatin (CisPt) treatment is limited by its toxicity, especially when higher doses are necessary, and the possible occurrence of cisplatin resistance. This study evaluated the effects of resveratrol (RSV) on the expression of different genes involved in the response of human tumor cells (FaDu, PE/CA-PJ49) to cisplatin therapy. Our results revealed that RSV induced apoptosis amplification in both FaDu and PE/CA-PJ49 cells and modulated the expression of specific genes differently than in normal HaCaT cells. In FaDu cells, combined CisPt + RSV treatment induced an increase in apoptosis, which was associated with an increase in <i>c-MYC</i> and <i>TP53</i> and a decrease in <i>BCL-2</i> expression. While CisPt + RSV treatment induced apoptosis in PE/CA-PJ49 cells by inhibition of <i>BCL-2</i> associated with high levels of <i>MDM-2</i> and subsequently led to inhibition of <i>TP53</i> gene expression. Decreased <i>c-MYC</i> expression in PE/CA-PJ49 treated with CisPt + RSV was accompanied by cell cycle blockage in G0/G1 phase. In conclusion, RSV influences tumor cell response to CisPt by inducing apoptosis and modulating gene expression. In addition, in normal HaCaT cells, RSV was able to reduce the harmful effects of CisPt.
first_indexed 2024-03-10T10:27:05Z
format Article
id doaj.art-2b8461f8b7f140f595cfda02608900d9
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T10:27:05Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-2b8461f8b7f140f595cfda02608900d92023-11-21T23:55:21ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-06-012212632210.3390/ijms22126322Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell LinesMarinela Bostan0Mirela Mihaila1Georgiana Gabriela Petrica-Matei2Nicoleta Radu3Razvan Hainarosie4Cristian Dragos Stefanescu5Viviana Roman6Carmen Cristina Diaconu7Center of Immunology, Stefan S. Nicolau Institute of Virology, 030304 Bucharest, RomaniaCenter of Immunology, Stefan S. Nicolau Institute of Virology, 030304 Bucharest, RomaniaPersonal Genetics-Medical Genetics Center, Department of Cytogenetics, 010987 Bucharest, RomaniaDepartment of Biotechnology, University of Agronomic Sciences and Veterinary Medicine of Bucharest, 011464 Bucharest, RomaniaOtorhinolaryngology and Head and Neck Surgery Department—Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaOtorhinolaryngology and Head and Neck Surgery Department—Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaCenter of Immunology, Stefan S. Nicolau Institute of Virology, 030304 Bucharest, RomaniaDepartment of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, 030304 Bucharest, RomaniaIn head and neck cancers, the effectiveness of cisplatin (CisPt) treatment is limited by its toxicity, especially when higher doses are necessary, and the possible occurrence of cisplatin resistance. This study evaluated the effects of resveratrol (RSV) on the expression of different genes involved in the response of human tumor cells (FaDu, PE/CA-PJ49) to cisplatin therapy. Our results revealed that RSV induced apoptosis amplification in both FaDu and PE/CA-PJ49 cells and modulated the expression of specific genes differently than in normal HaCaT cells. In FaDu cells, combined CisPt + RSV treatment induced an increase in apoptosis, which was associated with an increase in <i>c-MYC</i> and <i>TP53</i> and a decrease in <i>BCL-2</i> expression. While CisPt + RSV treatment induced apoptosis in PE/CA-PJ49 cells by inhibition of <i>BCL-2</i> associated with high levels of <i>MDM-2</i> and subsequently led to inhibition of <i>TP53</i> gene expression. Decreased <i>c-MYC</i> expression in PE/CA-PJ49 treated with CisPt + RSV was accompanied by cell cycle blockage in G0/G1 phase. In conclusion, RSV influences tumor cell response to CisPt by inducing apoptosis and modulating gene expression. In addition, in normal HaCaT cells, RSV was able to reduce the harmful effects of CisPt.https://www.mdpi.com/1422-0067/22/12/6322resveratrolcisplatinhead and neck carcinoma line<i>c-MYC</i><i>BCL-2</i><i>TP53</i>
spellingShingle Marinela Bostan
Mirela Mihaila
Georgiana Gabriela Petrica-Matei
Nicoleta Radu
Razvan Hainarosie
Cristian Dragos Stefanescu
Viviana Roman
Carmen Cristina Diaconu
Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines
International Journal of Molecular Sciences
resveratrol
cisplatin
head and neck carcinoma line
<i>c-MYC</i>
<i>BCL-2</i>
<i>TP53</i>
title Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines
title_full Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines
title_fullStr Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines
title_full_unstemmed Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines
title_short Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines
title_sort resveratrol modulation of apoptosis and cell cycle response to cisplatin in head and neck cancer cell lines
topic resveratrol
cisplatin
head and neck carcinoma line
<i>c-MYC</i>
<i>BCL-2</i>
<i>TP53</i>
url https://www.mdpi.com/1422-0067/22/12/6322
work_keys_str_mv AT marinelabostan resveratrolmodulationofapoptosisandcellcycleresponsetocisplatininheadandneckcancercelllines
AT mirelamihaila resveratrolmodulationofapoptosisandcellcycleresponsetocisplatininheadandneckcancercelllines
AT georgianagabrielapetricamatei resveratrolmodulationofapoptosisandcellcycleresponsetocisplatininheadandneckcancercelllines
AT nicoletaradu resveratrolmodulationofapoptosisandcellcycleresponsetocisplatininheadandneckcancercelllines
AT razvanhainarosie resveratrolmodulationofapoptosisandcellcycleresponsetocisplatininheadandneckcancercelllines
AT cristiandragosstefanescu resveratrolmodulationofapoptosisandcellcycleresponsetocisplatininheadandneckcancercelllines
AT vivianaroman resveratrolmodulationofapoptosisandcellcycleresponsetocisplatininheadandneckcancercelllines
AT carmencristinadiaconu resveratrolmodulationofapoptosisandcellcycleresponsetocisplatininheadandneckcancercelllines